System for pancreatic stimulation and glucose measurement

• US 20020026141A1
• Filed: 09/05/2001
• Published: 02/28/2002
• Est. Priority Date: 11/04/1999
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Houben, Richard P. M., Renirie, Alexis C.M., Weijand, Koen J.
• Application Number:
  US09/945,686
• Publication Number:
  US 20020026141A1
• Time in Patent Office: Days
• US Class Current: 604/66
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/352 Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
• CPC Class Codes: A61B 5/425 pancreas
• CPC Class Codes: A61B 5/7207 of noise induced by motion artifacts
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

There is provided an implantable system and method for monitoring pancreatic beta cell electrical activity in a patient in order to obtain a measure of a patient'"'"'s insulin demand and blood glucose level. A stimulus generator is controlled to deliver stimulus pulses so as to synchronize pancreatic beta cell depolarization, thereby producing an enhanced electrical signal which is sensed and processed. In a specific embodiment, the signal is processed to determine the start and end of beta cell depolarization, from which the depolarization duration is obtained. In order to reduce cardiac interference, each stimulus pulse is timed to be offset from the QRS signal which can interfere with the pancreas sensing. Additionally, the beta cell signals are processed by a correction circuit, e.g., an adaptive filter, to remove QRS artifacts, as well as artifacts from other sources, such as respiration. The thus obtained insulin demand signal is used either to control delivery of insulin from an implanted insulin pump, or to control ongoing pancreatic stimulation of a form to enhance insulin production.

Claims

1. A system for sensing insulin demand of a patient, comprising:

stimulating means for delivering stimulating pulses to the pancreas of said patient;

sensing means for sensing the electrical responses of said pancreas to said stimulating pulses and obtaining signals representative of said responses; and

processing means for processing said signals and deriving therefrom a measure of the insulin demand of said patient.

2. The system as described in claim 1, wherein said processing means comprises first means for obtaining data representative of the duration of the depolarization burst of pancreatic beta-cells following delivery of a said stimulating pulse.

3. The system as described in claim 2, comprising heart sensing means for sensing cardiac signals from said patient, and control means responsive to said cardiac signals for controlling said stimulating means to deliver each said stimulus pulse at a time substantially free of cardiac signal interference, thereby enhancing detection of said burst duration.

4. The system as described in claim 3, comprising R-wave means for determining the occurrence of cardiac QRS complexes, and wherein said control means comprises timing means for timing a next stimulating pulse at a predetermined delay following the last said QRS complex, thereby enhancing detection of the onset of said burst.

5. The system as described in claim 1, comprising initiate means for automatically controlling said stimulating means to initiate delivering of stimulus pulses on a predetermined timing schedule.

6. The system as described in claim 1, comprising external means for sending signals from an external location to enable said stimulating means to deliver stimulus pulses.

7. The system as described in claim 1, wherein said stimulating means comprises electrodes positionable with respect to said patient'"'"'s pancreas so as to deliver stimulus pulses and to sense electrical activity of a plurality of islets of Langerhans within the patient'"'"'s pancreas.

8. The system as described in claim 1, wherein said processing means comprises means for determining the duty cycle of the depolarization burst of pancreatic beta-cells following a delivered stimulus pulse.

9. The system as described in claim 1, wherein said processing means comprises means for determining a measure of the spike frequency of the depolarization burst of pancreatic beta-cells following a delivered stimulus pulse.

10. The system as described in claim 1, wherein said processing means comprises data storage means for storing data representative of said signals for a plurality of stimulus pulses, and means for deriving said insulin demand measure as a function of said stored data.

11. The system as described in claim 1, in combination with insulin means for delivering insulin to said patient, and delivery control means for controlling said insulin means to deliver insulin as a function of said insulin demand measure.

12. The system as described in claim 11, wherein said system is implantable, and further comprising external means for communicating to said implantable system commands for stimulating said pancreas and obtaining said insulin demand measure.

13. The system as described in claim 1, comprising timing means for timing delivery of a said stimulating pulse to occur during a period of pancreatic beta cell re-polarization.

15. The system as disclosed in claim 14, wherein said stimulus means comprises pulse generating means for generating stimulus pulses and lead means for delivery of a stimulus pulse to said predetermined location.

16. The system as disclosed in claim 15, wherein said lead means comprises electrodes for delivering said pulses to the patient'"'"'s pancreas.

17. The system as described in claim 15, wherein said lead means comprises electrodes positioned for delivery of said pulses to a transplant of islets of Langerhans.

18. The system as described in claim 16, comprising control means for controlling delivery of a said stimulus pulse at a time when the beta-cell activity of said pancreas is in a quiet phase and at a predetermined delay after occurrence of a QRS complex in said patient'"'"'s heart.

19. The system as described in claim 14, wherein said stimulus means comprises means for delivering stimulus pulses to the patient'"'"'s pancreas, and control means for controlling said stimulus means to generate a stimulus pulse just before the expected start of a beta cell repolarization burst.

14. An implantable closed loop insulin delivery system for delivering insulin to a patient, comprising:

stimulus means for stimulating pancreatic beta cells within a predetermined location of said patient;

sensing means for sensing electrical activity of said beta cells following a said stimulating;

measure means for determining from said sensed electrical activity a measure of the patient'"'"'s blood glucose level; and

insulin delivery means for delivering insulin to said patient in response to a determined said measure greater than a predetermined level.

20. A method of obtaining a measure of blood glucose in a patient, comprising:

(a) delivering at least one stimulus pulse to a location of said patient containing pancreatic beta cells;

(b) sensing the electrical response of said pancreatic beta cells to said stimulus pulse and obtaining a signal representative of said response; and

(c) processing said at least one signal and deriving therefrom a measure of patient blood glucose level.

21. The method as described in claim 20, comprising delivering said at least one stimulus pulse to the patient'"'"'s pancreas, and timing the delivery of said stimulus pulse to occur while the patient'"'"'s pancreatic beta cells are in a quiet phase.

22. The method as described in claim 21, comprising sensing a plurality of pancreatic beta cell depolarization-repolarization cycles, and determining a next anticipated onset of a repolarization phase, and timing said at least one stimulus pulse to be delivered just before the next expected repolarization onset.

23. A method as described in claim 22, comprising sensing QRS signals of said patient'"'"'s heart and controlling said delivery of said at least one stimulus pulse to occur at a time not coincident with the QRS.

24. The method as described in claim 23, comprising sensing the depolarization burst duration of the patient'"'"'s pancreas following a delivered stimulus pulse, and determining blood glucose level as a function of said determined duration.

25. The method as described in claim 20, further comprising delivering stimulus pulses to a predetermined nerve location to synchronize the electrical activity of said pancreatic beta cells.

27. The system as described in claim 26, wherein said stimulating means comprises nerve delivery means for delivering said stimulus pulses to a predetermined patient nerve location.

28. The system as described in claim 27, wherein said nerve delivery means comprises vagal means for delivering said stimulus pulses to the patient'"'"'s vagal nerve.

29. The system as described in claim 26, wherein said stimulating means comprises pancreas delivery means for delivering said stimulus pulses to the patient'"'"'s pancreas.

30. The system as described in claim 29, wherein said pancreas delivery means comprises plural electrode pairs at different pancreatic location.

26. A system for providing improved sensing of pancreatic beta cells, whereby to obtain information representative of patient insulin demand, comprising:

stimulating means for generating and delivering stimulus pulses to a predetermined patient location;

sensing means for sensing electrical activity of pancreatic beta cells within said patient, said sensing means being operatively coordinated with said stimulating means so as to sense beta cell responses following said stimulus pulses, and

processing means for processing said signals and deriving therefrom a measure of the insulin demand of said patient.